Drawing for OPTIFRZ

USPTO serial 97490184

OPTIFRZ

Reviewed by CopyMark Law Group

Reg. 7197779Status 700Registered
Filing date
Status date
Registration date
Oct 17, 2023
Examiner
MCBRIDE, CAMERON L
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with OPTIFRZ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Crissa A. Cook

Crissa A. Cook HOVEY WILLIAMS LLP10801 MASTIN BLVD., SUITE 1000OVERLAND PARK, KS 66210UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Cell culture media for laboratory use; cell culture media for use in scientific research; non-animal derived cell culture media and media supplements in the nature of proteins, peptides and enzymes for growing cells for scientific and research use; nonanimal derived biological preparations for use in cell cultures other than for medical or veterinary use; cell culture media for manufacturing of gene therapies, vaccines, cell therapies, and regenerative medicines; cryopreservation media, used for freezing biological specimens, comprising cell culture media for scientific, diagnostic, or laboratory research; biopreservation media products, namely, chemical preparations for preservation of cells, tissues and organs, for scientific and research useACTIVE—
005Non-animal derived cell culture media for cultivating human, animal, plant or microorganism cells for medical purposes; cell culture reagents for medical and clinical medical use; cell culture reagents for medical diagnostic use; cell culture media for cryopreservation of cells for medical and veterinary use; cryopreservation culture media for use in freezing cells for medical and veterinary use; biopreservation media products, namely, chemical preparations for preservation of cells, tissues and organs, for medical and veterinary useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 17, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 17, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 13, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 12, 2023SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 11, 2023CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 23, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 23, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 14, 2023IUAFUSE AMENDMENT FILED—
Aug 14, 2023EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 14, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 20, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 20, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 30, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 14, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 28, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Oct 28, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 28, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 28, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 7, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 7, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 7, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 31, 2022DOCKASSIGNED TO EXAMINER—
Jul 11, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 9, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance